Search results for ' Intellectual Property'.
Sun Pharma sues Novartis in US court
Rediff.com13 Jun 2013In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.
You better stop cybertheft, Obama warns China's Xi
Rediff.com9 Jun 2013Spread over two days -- Friday and Saturday -- at a picturesque desert resort in Southern California, Obama, 51, and Xi, 59, had several rounds of meetings and a candle-lit dinner spread over nearly eight hours on a range of bilateral, regional and global issues.
Obama meets Xi; says US hails 'peaceful rise' of China
Rediff.com8 Jun 2013Welcoming "peaceful rise" of China as a world power, United States President Barack Obama Friday greeted his Chinese counterpart Xi Jinping at Palm Springs in California for a two day summit, with both leaders calling for a new approach to ties between Washington and Beijing.
Apple patent case exposes trade arbiter's flaws
Rediff.com6 Jun 2013A US ban on imports of older iPhones and iPads is example of the International Trade Commission being too quick to block products on dubious grounds.
All about investing in property rights
Rediff.com29 May 2013States must invest in both physical infrastructure and the institutional infrastructure that supports markets.
Ranbaxy a wake-up call for Indian pharma
Rediff.com25 May 2013Industry must take strong collective action to protect the reputation it enjoys in global markets, says Kiran Mazumdar Shaw.
1% rise in licenced software use can add $1.3b to GDP
Rediff.com21 May 2013The study titled 'Competitive advantage: The economic impact of properly licensed software' analyses data from 95 countries to demonstrate the benefits to their national economies by using fully licenced software.
Harvard grad, activist, Soros Fellow: Meet Amar Bakshi
Rediff.com20 May 2013In a three-part series commencing today, Arthur J Pais profiles some of the winners of the Paul and Daisy Soros Fellowships for New Americans. First up is Amar Bakshi, who fought and won a legal battle to uphold the freedom of the press in Zimbabwe and has studied at Harvard, John Hopkins and now Yale.
Activist, jailbird, Yale grad: Amar Bakshi
Rediff.com20 May 2013Soros scholar Amar Bakshi shares his journey.
US think tank seeks suspension of trade policies with India
Rediff.com15 May 2013From Lalit K Jha Washington, May 15 (PTI) Alleging that recent trade policies of India are jeopardising its trade ties with the US, a Washington-based think tank has recommended the Congress to suspend trade benefits for New Delhi. "To be clear, a strong, growing, and collaborative trade relationshi ...
Now, drug info just an SMS away
Rediff.com13 May 2013The government is set to roll out an SMS-based helpline, which will enable consumers to seek information on various brands available in the market for their specific composition, with their prices.
'India, EU yet to reach consensus on FTA'
Rediff.com8 May 2013While the 27-nation bloc is pressing hard for a significant duty cut in automobile sector in the proposed Broad based Trade and Investment Agreement, Indian industry is strongly opposed to such a move.
Tata Motors wins Jaguar trademark battle
Rediff.com2 May 2013The order comes in response to a petition filed by Jaguar Cars Ltd seeking to quash the decision of deputy registrar of Trade Marks, Kolkata.
India-EU FTA negotiations have been intensified: Min
Rediff.com22 Apr 2013So far 15 rounds of negotiations have been held.
Will China export nuclear reactors to Pakistan?
Rediff.com20 Apr 2013China has declared that it has acquired the first foreign contract for its self-developed 1000 MW nuclear reactor, hinting that it could be exported to Pakistan, overriding the concerns of both United States and India. ACP1000, a third-generation nuclear reactor developed independently by China National Nuclear Corporation, has secured its first foreign contract, the company said on Friday.
'Talks on India-EU FTA progressing very well'
Rediff.com18 Apr 2013During the talks, both sides failed to reach on a conclusion and has agreed to meet again in June.
'Fine balance needed on market access for FTA'
Rediff.com16 Apr 2013Commerce and Industry Minister Anand Sharma and European Union Trade Commissioner Karel De Gucht concluded another round of talks on Monday at the European Commission headquarters in Brussels, which the Commission said 'provided a renewed momentum to bring the negotiations forward'.
COLUMN: Struggle for life saving drugs
Rediff.com16 Apr 2013People die from diseases like AIDS, TB, etc because life saving essential medicines are either too expensive, or not available because they are not seen as financially viable.
Novartis has 219 patents in India
Rediff.com15 Apr 2013Data contradict Swiss drug major's claim that India does not respect IPR.
Infosys to tilt salaries towards fixed pay
Rediff.com13 Apr 2013Move to help employees get more without raising their salary base
India refutes US criticism of its FDI, IPR laws
Rediff.com13 Apr 2013USTR has said India imposed several barriers in major services industries such as insurance, banking, audiovisual, accounting, legal, telecommunications, distribution services, postal and express delivery services.
Should pharma MNCs be peeved?
Rediff.com12 Apr 2013In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.
Drug patent row: HC to hear US co on Apr 12
Rediff.com10 Apr 2013A bench of justices Sanjay Kishan Kaul and Indermeet Kaur took the plea of US pharma major on record and posted it for hearing before another bench on April 12.
Patent row: HC refuses interim relief to Merck
Rediff.com5 Apr 2013The development assumes significance as on Monday the Supreme Court had rejected the plea of Novartis AG for patent protection of its anti-cancer drug Glivec.
'Telecom sector: Brazil, India posing barriers'
Rediff.com4 Apr 2013In its annual report on telecom sector, the US Trade Representative also said there were barrier concerns regarding supplying satellite services in China and India.
Novartis ruling to impact innovation: US biz groups
Rediff.com4 Apr 2013Sector observers refute, call response a bluff.
'Novartis ruling won't affect pharma industry'
Rediff.com3 Apr 2013Oncologist Dr Sthabir Dasgupta talks about the impact of Novartis's losing patent case on the Indian pharma industry.
'US industry reviewing SC decision on Novartis'
Rediff.com3 Apr 2013The US India Business Council expressed its unease over the Supreme Court on denying a patent on Glivec and said that this would impact innovation and investment climate in India as a time when the country needs foreign direct investment the most.
Merck moves HC against Glenmark
Rediff.com3 Apr 2013Merck alleges violation of its patent for anti-diabetes drugs Januvia and Janumet.
Indian pharma has no incentive to innovate
Rediff.com2 Apr 2013Decision by the Supreme Court denying a patent to Glivec discourages innovative drug discovery.
Domestic pharma lauds apex court verdict
Rediff.com2 Apr 2013Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up.
SC decision on Novartis "historic": Anand Sharma
Rediff.com1 Apr 2013Says Indian Patent Law conforms fully with global obligations under the WTO IPR pact-TRIPS.
SC decision on Novartis to benefit poor: Pharma cos
Rediff.com1 Apr 2013Terming the judgement as a 'landmark judgement' in favour of poor patients, domestic drug manufacturer associations, including Indian Pharmaceutical Alliance and Indian Drug Manufacturers' Association, hailed the apex court's decision.
Will not invest on R&D in India, says Novartis
Rediff.com1 Apr 2013The company will continue to introduce products in the country, but not invest in R&D here, Novartis India Ltd Vice-Chairman and Managing Director Ranjit Shahani said at a press conference in Mumbai.
SC denies patent to Novartis's cancer drug Glivec
Rediff.com1 Apr 2013In a landmark judgment that has the potential to change the direction of India's pharmaceutical business, the apex court said on Monday that the drug failed to qualify for a patent according to Indian law.
Quarter of US firms in China face data theft
Rediff.com29 Mar 2013Twenty-six per cent of members who responded to an annual survey said their proprietary data or trade secrets had been compromised or stolen from their China operations, the American Chamber of Commerce in China report said.
Big Pharma waits nervously on Glivec patent verdict
Rediff.com28 Mar 2013Supreme Court will give its verdict on April 1 on whether Swiss giant Novartis AG's cancer treatment drug Glivec deserves a patent in the country not it doesn't.
Brokerages give Nestle thumbs-down
Rediff.com26 Mar 2013Brokerage houses reacted to the piece of news by reducing the target price assigned to the company.
Are IT outsourcers promoting mini CEOs?
Rediff.com25 Mar 2013For young graduates who see the $108 billion IT industry as a sure pathway to modern India's growing middle class, the transformation is unsettling.
'Fight for privacy or you will lose it'
Rediff.com22 Mar 2013Google Executive Chairman Eric Schmidt made a pitch for protecting privacy as the Internet becomes more widely accessible in India.